Key Highlights

  • Vitasora Health shares traded up 9.09% at $0.012 during the 11 November 2026 trading session.
  • Patients in its US chronic care management program were ahead of national benchmarks after about six months and improved further by about 12 months.
  • Care Coordinator utilisation rose above 95%, and monthly billable care minutes grew by about 50% to 262,104 in October.

Vitasora Health Ltd (ASX:VHL) shares were trading at $0.012 during the session on 11 November 2026, up 9.09% by late morning. The S&P/ASX 200 (ASX:XJO) was down about 0.06% at 9,123.90 at 12:19 pm. Vitasora provides chronic care management services in the United States. On 9 November 2026, the company announced patient outcome results and developments in its US operations.

 

Diabetes and Blood Pressure Outcomes

Vitasora said patients in its chronic care management program, delivered with a US Federally Qualified Health Center, were already outperforming national health center benchmarks after about six months. After about 12 months, the share of patients with poorly controlled diabetes fell from 13.1% to 6.7%, against a national benchmark of 28.1%. Blood pressure control rose to 82.9%, compared with 67.4% nationally.

 

Behavioural Coaching Approach

The company said its THRIVE Coaching program uses behavioural science, including motivational interviewing and patient activation assessment, to build patient confidence in making small, everyday lifestyle changes. Vitasora presents this as a key part of its outcomes.

 

Operational Growth

The company said better clinical workflows, its V-care platform and a strengthened US management team lifted Care Coordinator utilisation above 95%. Monthly billable care minutes rose by approximately 50% to 262,104 minutes in October.

 

Capacity Build-Out

Vitasora had 42 active Care Coordinators at the end of October 2026, with a target of approximately 115 by late in the first quarter of calendar 2027. The company said indicative Revenue capacity is approximately US$595 per fully productive Care Coordinator per day.

 

Growth Opportunities

Vitasora said the outcomes give it real-world evidence to present to existing customers looking to expand services and to new prospects. The company linked these opportunities to its agreement with Treasure Coast Community Health.

 

Sector Context

Chronic care management and value-based care services in the United States depend on demonstrating measurable outcomes to healthcare providers and payers. Care delivery businesses are often judged on utilisation, patient engagement and the ability to scale their coordination teams, and small listed operators can see their share prices move on evidence of these metrics.

 

Key Risks

The outcome results describe patients within a specific program, and they may not be representative of other settings. The company’s revenue capacity depends on hiring and deploying Care Coordinators to reach the target of about 115 by late in the first quarter of 2027, and it currently has 42 active. Its growth also depends on converting the Treasure Coast opportunity and on attracting new customers. As a very low-priced stock, Vitasora’s shares can be volatile.

 

What to Watch Ahead

Investors will be watching the hiring of Care Coordinators toward the target, the monthly billable minutes trend in the coming months and any new customer agreements. Further patient outcome updates will also be relevant to the company’s growth story.

 

Final Word

Vitasora’s Trading session on 11 November 2026 followed an update that highlighted patient outcomes and operational growth in its US program. The next stage will depend on whether the Care Coordinator build-out and customer expansion keep pace with the outcomes reported.